These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17107609)

  • 21. [Open randomized comparative trial of sodium valproate and carbamazepine in adult onset epilepsy].
    Czapiński P; Terczyński A
    Neurol Neurochir Pol; 1996; 30(3):419-26. PubMed ID: 8965976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
    Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
    J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological outcomes in newly diagnosed epilepsy.
    Mohanraj R; Brodie MJ
    Epilepsy Behav; 2005 May; 6(3):382-7. PubMed ID: 15820347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Benzodiazepine withdrawal with carbamazepine].
    Kaendler SH; Volk S; Pflug B
    Nervenarzt; 1996 May; 67(5):381-6. PubMed ID: 9005346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review: Adjunctive pharmacologic approaches for benzodiazepine tapers.
    Welsh JW; Tretyak V; McHugh RK; Weiss RD; Bogunovic O
    Drug Alcohol Depend; 2018 Aug; 189():96-107. PubMed ID: 29906718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial.
    Malcolm R; Myrick H; Roberts J; Wang W; Anton RF; Ballenger JC
    J Gen Intern Med; 2002 May; 17(5):349-55. PubMed ID: 12047731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The sequential use of clonidine and naltrexone in the treatment of opiate addicts.
    Gold MS; Dackis CA; Washton AM
    Adv Alcohol Subst Abuse; 1984; 3(3):19-39. PubMed ID: 6388273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An open trial of low dose buprenorphine in treating methadone withdrawal.
    Banys P; Clark HW; Tusel DJ; Sees K; Stewart P; Mongan L; Delucchi K; Callaway E
    J Subst Abuse Treat; 1994; 11(1):9-15. PubMed ID: 8201637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid detoxification using high doses of buprenorphine in 24 hours: a randomized, double blind, controlled clinical trial.
    Assadi SM; Hafezi M; Mokri A; Razzaghi EM; Ghaeli P
    J Subst Abuse Treat; 2004 Jul; 27(1):75-82. PubMed ID: 15223097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids.
    Cheskin LJ; Fudala PJ; Johnson RE
    Drug Alcohol Depend; 1994 Oct; 36(2):115-21. PubMed ID: 7851278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of outpatient alcohol detoxification with a combination of tiapride/carbamazepine: additional evidence.
    Soyka M; Schmidt F; Schmidt P
    Pharmacopsychiatry; 2006 Jan; 39(1):30-4. PubMed ID: 16453252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative strategies of opiate detoxification: evaluation of the so-called ultra-rapid detoxification.
    Scherbaum N; Klein S; Kaube H; Kienbaum P; Peters J; Gastpar M
    Pharmacopsychiatry; 1998 Nov; 31(6):205-9. PubMed ID: 9930633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticonvulsant drugs in the treatment of substance withdrawal.
    Zullino DF; Khazaal Y; Hättenschwiler J; Borgeat F; Besson J
    Drugs Today (Barc); 2004 Jul; 40(7):603-19. PubMed ID: 15510234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A randomized single blind study of the efficacy of pregabalin in the treatment of opioid withdrawal syndrome].
    Krupitsky EM; Ilyuk RD; Mikhailov AD; Kazankov KA; Rybakova KV; Skurat EP; Grishina OG; Zaplatkin IA; Vetrova MV; Neznanov NG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(7):29-36. PubMed ID: 27500873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy.
    Hessen E; Lossius MI; Reinvang I; Gjerstad L
    Epilepsia; 2006 Dec; 47(12):2038-45. PubMed ID: 17201701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) project: an open-label pragmatic randomised control trial comparing the efficacy of differing therapeutic agents for primary care detoxification from either street heroin or methadone [ISRCTN07752728].
    Oldham NS; Wright NM; Adams CE; Sheard L; Tompkins CN
    BMC Fam Pract; 2004 Apr; 5():9. PubMed ID: 15117415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topiramate in opiate withdrawal.
    Zullino DF; Cottier AC; Besson J
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1221-3. PubMed ID: 12452551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbamazepine treatment of cocaine dependence in methadone maintenance patients with dual opiate-cocaine addiction.
    Kuhn KL; Halikas JA; Kemp KD
    NIDA Res Monogr; 1989; 95():316-7. PubMed ID: 2640978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonidine in outpatient detoxification from methadone maintenance.
    Kleber HD; Riordan CE; Rounsaville B; Kosten T; Charney D; Gaspari J; Hogan I; O'Connor C
    Arch Gen Psychiatry; 1985 Apr; 42(4):391-4. PubMed ID: 3977557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of opiate withdrawal symptoms with use of clonidine in a county jail.
    Fresquez-Chavez KR; Fogger S
    J Correct Health Care; 2015 Jan; 21(1):27-34. PubMed ID: 25431436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.